Researchers conducted a small pilot study to see if it is possible to run a larger trial comparing two common anesthesia drugs. The study involved 93 patients booked for endovascular thrombectomy, a procedure to clear blocked arteries in the brain. The goal was to test how easy it is to recruit patients and follow the study rules, rather than to prove which drug works best.
The team found that the study process worked well. They successfully enrolled 46% of eligible patients and followed the protocol in over 94% of cases. Data was collected completely in 99% of records. When comparing the two anesthesia groups, there were no differences in functional recovery, death, or early brain improvement. The study also looked at blood pressure control and adverse events, but no specific safety issues were reported.
Because this was a feasibility pilot, no conclusions can be drawn about whether one drug causes better outcomes than the other. The main finding is that future, larger studies could work if they adapt the research model to fit better into clinical workflows. Readers should understand that these preliminary results are not enough to change current medical practice or recommend one drug over another for stroke patients.
